CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

The Comparison of Adverse Effect and Short - term Effect of Different Dosage of Recombinant Interferon Alpha - 2b Treatment in Patients with Chronic Active Hepatitis Type B

Clin Mol Hepatol. 1998;4(1):12-22.

Interferon production in patients with chronic active hepatitis B during treatment with recombinant interferon alpha

Journal of Hepatology. 1988;7:S72

Link1 Link2

Treatment of chronic hepatitis non-A-non-B with recombinant interferon-alpha-2b — preliminary findings

Journal of Hepatology. 1987;5:S124

Link1 Link2

Low doses of recombinant alpha 2B interferon in chronic hepatitis B

Journal of Hepatology. 1987;5:S112

Link1 Link2

Treatment of chronic hepatitis C with recombinant alfa interferon 2B

Gastroenterology. 1995;108(4):A1155

Link1 Link2

Comparison of the effect of gamma interferon and alpha interferon on serum ALT level in chronic active hepatitis non A non B

Journal of Hepatology. 1988;7:S57

Link1 Link2

The effect of recombinant interferon alpha treatment on hearing thresholds in patients with chronic viral hepatitis B

Kemal Görür, Özlem Kandemir, Murat Ünal, Cengiz Özcan

Auris Nasus Larynx. 2003;30(1):41-44

Link1 Link2

Pilot study of interferon $alpha;-2B treatment of chronic active hepatitis C in patients co-infected with the human immunodeficiency virus 6HIV-19

E SCHWARZ

Hepatology. 1993;18(4):A254

Link1 Link2

Randomized comparative study of recombinant alpha and lymphoblastoid interferon in patients with chronic active hepatitis C

Journal of Hepatology. 1994;21:S27

Link1 Link2

Chronic HBV treatment with one year of pegylatyed-interferon alpha-2b (PEG-IFN) has a comparable safety profile to short term conventional interferon alpha-2b

M. van Zonneveld, A.B. van Nunen, R.A. de Man, S.W. Schalm, H.L.A. Janssen

Journal of Hepatology. 2003;38:179

Link1 Link2

Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study

M Michallet, F Maloisel, M Delain, A Hellmann, A Rosas, R T Silver, C Tendler,

Leukemia. 2003;18(2):309-315

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.